Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)
PHASE4
Background: In European Association of Urology (EAU) Guidelines, the vast m...
Status
Recruiting
Location
AOU Policlinico Umberto I Hospital, UOC Urologia SMUC05, Rome, Italy
A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk.
PHASE2
This prospective, multicenter, single-arm phase II trial aims to evaluate t...